# New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

> **Open Intelligence Dossier** · First detected: 2026-10-25 11:20 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent&quot; is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance and Endpoints News. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Merck CEO Plays Down Cost Concerns Over Intismeran — ‘We Don't See Cost As A Limit To Access’ | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxOOWJYaUhpMTlabS1HakllMVNqQjlUN0RpdDVaMDA3Rm82YU8wR1FsamlDRng4dmp3aTU4MEUySVlSM1dIZ1p3TjMydm5oOHVlOVdQZFhZVGc5dHM5OWJuOGNpbExXQWdBbEpYQlk1OTJVQlMtQWZpdnA3TUJkR0ZkOUNPTDh3VWdnUFFJLVdRZw?oc=5) |
| Endpoints News | Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxQdnNCT0NoSmc5VTJNR2FKallXck9iMHNvNnJ1bWl0NV8yS3lUdC11RUo4SG1ZMTBJOTNGYko1RjJIaXFNNnAyQjZtdGFOUG9VcFUyQVZ2aUhpTVJ0MDZ1VXR4QUNSZkk1YTdXYTdmUVBjMEJwbmRoSXpGd0ZkVTRZcmpKSDlfSGFiUy1HRDNBeS1YSVJuck1JRmJ2dFpZN1MyMnNKM25weldfQkFIWGpIMWdJQ3RuX01KdU9z?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-25/new-mrna-vaccine-reduces-risk-of-melanoma-recurrence-by-over-40-percent*
